VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Sunday, January 11, 2026
Stock Comparison
FedEx Corporation vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
FedEx Corporation
FDX · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into FedEx Corporation's moat claims, evidence, and risks.
View FDX analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 72 / 100 for FedEx Corporation).
- Segment focus: FedEx Corporation has 3 segments (85.6% in Federal Express (integrated parcel & express)); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: FedEx Corporation has 6 moat types across 4 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
FedEx Corporation
Federal Express (integrated parcel & express)
Integrated parcel and express delivery (air-ground integrator model)
Global
Business and consumer shippers
Carrier / integrator
85.6%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
FedEx Corporation strengths
Novo Nordisk A/S strengths
Segment mix
FedEx Corporation segments
Full profile >Federal Express (integrated parcel & express)
Oligopoly
FedEx Freight (LTL)
Oligopoly
Corporate, other, and eliminations (Dataworks, Office, Logistics)
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.